BOT 9.68% 34.0¢ botanix pharmaceuticals ltd

Ann: Successful Completion of Human Factors Study, page-37

  1. 411 Posts.
    lightbulb Created with Sketch. 107
    BOT management not wasting anytime. This is my opinion approval may be much earlier than mid 2024 I don't think FDA will take the full 6mths to approve a label and hand washing instructions. Sofdra is a turning point for this company I hope they can acquire more late stage products in the coming years lower risk, cheaper and faster time to market.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.030(9.68%)
Mkt cap ! $615.4M
Open High Low Value Volume
31.0¢ 34.3¢ 30.8¢ $3.843M 11.64M

Buyers (Bids)

No. Vol. Price($)
4 106766 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 353068 6
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.